These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5115695)

  • 1. Heterocyclic steroids. 3. An androgen having three heteroatoms in ring A.
    Zanati G; Wolff ME
    J Med Chem; 1971 Oct; 14(10):961-2. PubMed ID: 5115695
    [No Abstract]   [Full Text] [Related]  

  • 2. Heterocyclic steroids. 2. Synthesis and androgenic activity of A-ring oxaandrostanes.
    Zanati G; Wolff ME
    J Med Chem; 1971 Oct; 14(10):958-61. PubMed ID: 5115694
    [No Abstract]   [Full Text] [Related]  

  • 3. Heterocyclic steroids. 4. Synthesis and androgenic activity of A-ring homosteroids.
    Zanati G; Wolff ME
    J Med Chem; 1972 Apr; 15(4):368-9. PubMed ID: 5019551
    [No Abstract]   [Full Text] [Related]  

  • 4. Heterocyclic steroids. 5. Sulfur, selenium, and tellurium 5alpha-androstane derivatives and their 7alpha-methylated congeners.
    Zanati G; Gaare G; Wolff ME
    J Med Chem; 1974 May; 17(5):561-3. PubMed ID: 4830264
    [No Abstract]   [Full Text] [Related]  

  • 5. Thia steroids. I. 2-Thia-A-nor-5-alpha-androstan-17-beta-ol, an active androgen.
    Wolff ME; Zanati G
    J Med Chem; 1969 Jul; 12(4):629-31. PubMed ID: 5793153
    [No Abstract]   [Full Text] [Related]  

  • 6. Preparation of some 7-oxaandrostane derivatives.
    Guthrie RW; Boris A; Mullin JG; Mennona FA; Kierstead RW
    J Med Chem; 1973 Mar; 16(3):257-62. PubMed ID: 4733108
    [No Abstract]   [Full Text] [Related]  

  • 7. Cycloprop(16 ,17 )androstanes.
    Fahrenholtz KE; Meyes KP; Kierstead RW
    J Med Chem; 1972 Oct; 15(10):1056-60. PubMed ID: 5069774
    [No Abstract]   [Full Text] [Related]  

  • 8. New classes of orally active hormonal derivatives. II. 17-Cycloalk-1'-enyl ethers of 17 -hydroxy-androstanes and 19-norandrostanes.
    Gardi R; Falconi G; Pedrali C; Vitali R; Ercoli A
    Steroids; 1972 May; 19(5):639-47. PubMed ID: 5041787
    [No Abstract]   [Full Text] [Related]  

  • 9. Preparation and androgenic activity of novel heterocyclic steroids.
    Wolff ME; Zanati G
    Experientia; 1970 Oct; 26(10):1115-6. PubMed ID: 5530063
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and myotrophic-androgenic activity of substituted 2-alpha, 3-alpha-methano-5-alpha-androstane derivatives.
    Wolff ME; Cheng SY; Ho W
    J Med Chem; 1968 Jul; 11(4):864-8. PubMed ID: 5671257
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and anabolic/androgenic evaluation of novel 9alpha-fluorosteroids.
    Reyes-Moreno M; Ruiz-García JA; Ibarra-Reyes Y; Fuente-Hernández A; Vélez-Castro H; Hernández-Balmaseda I; Martínez-Hormaza I; Rodeiro-Guerra I; Ramírez JS; Reyes SM; Montiel-Smith S
    Eur J Med Chem; 2009 Nov; 44(11):4567-71. PubMed ID: 19615789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some aspects of the relation between chemical structure of steroids and their prostatotropic effect in rats.
    de Visser J
    Acta Physiol Pharmacol Neerl; 1967 Dec; 14(4):527-8. PubMed ID: 5582730
    [No Abstract]   [Full Text] [Related]  

  • 13. Preparation of 7-chloro steroids.
    Guthrie RW; Boris A; Mennona FA; Mullin JG; Kierstead RW
    J Med Chem; 1973 Jan; 16(1):65-8. PubMed ID: 4682203
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and myotrophic-androgenic activity of 17beta-hydroxy-5alpha-androst-8(14)-en-3-one derivatives.
    Wolff ME; Chang HH
    J Med Chem; 1970 Sep; 13(5):967-8. PubMed ID: 5458391
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of 5alpha-reduced androgens on maintenance and regeneration of prostate glands and seminal vesicles in castrated and hypophysectomized rats.
    Ahmad N; Warren DW; Haltmeyer GC
    Anat Rec; 1978 Dec; 192(4):543-54. PubMed ID: 736274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations on steroids. IX. Pharmacological studies. (3). Myotrophic and androgenic activities of 17beta-hydroxy-5alpha-androstano-[2,3-c]furazan and its derivatives.
    Kasahara A; Onodera T; Oshima Y; Shimizu M
    Chem Pharm Bull (Tokyo); 1968 Aug; 16(8):1456-9. PubMed ID: 5708248
    [No Abstract]   [Full Text] [Related]  

  • 17. Dissociation of anabolic and androgenic properties of steroids by anti-anabolic and anti-androgenic agents in rats.
    Steinetz BG; Giannina T; Butler M; Popick
    Endocrinology; 1971 Sep; 89(3):894-6. PubMed ID: 5566400
    [No Abstract]   [Full Text] [Related]  

  • 18. Steroids. XXX. Some indolocholestanes and indoloandrostanes.
    Doorenbos NJ; Wu MT
    J Med Chem; 1968 Jan; 11(1):158-9. PubMed ID: 4966060
    [No Abstract]   [Full Text] [Related]  

  • 19. A new antiandrogen, 6alpha-bromo-17 beta-hydroxy-17 alpha-methyl-4-oxa-5 alpha-androstan-3-one.
    Boris A; Uskoković M
    Experientia; 1970 Jan; 26(1):9-10. PubMed ID: 5412314
    [No Abstract]   [Full Text] [Related]  

  • 20. The causes of the prolonged action of 5-alpha-androst-2-EN-17-beta-OL.
    Cekan Z; Bartosek I
    Steroids; 1967 Jul; 10(1):75-81. PubMed ID: 6059114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.